We demonstrated that DYRK1A inactivation sensitized PC cells to X-rays, and targeted DYRK1A inhibitor Harmine strongly synergized with radiotherapy, leading to increased cell death and anti-tumor effect. The gene discussed is DYRK1A; the disease is neoplasm.